deferasirox
SpainDrugs containing this active substance
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassemia major. It is also used in other types of anemia and in children aged 2 to 5 years when other treatments are not suitable.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Abdi Farma Gmbh
-
It is used to remove excess iron from the body (chronic iron overload) in patients with beta thalassemia major or with other types of anemias that require frequent blood transfusions or present iron overload due to other causes.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Abdi Farma Gmbh
-
It is used to remove excess iron from the body (chronic iron overload) in patients with beta thalassemia major, other types of anemia, or thalassemia syndromes.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to remove excess iron from the body (chronic iron overload). It is common in patients with beta thalassemia major who receive frequent blood transfusions, as well as in other types of anemia or in people with thalassemia syndromes who are non-transfusion dependent.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to remove excess iron from the body (chronic iron overload) in patients with beta thalassemia major or other types of anemias who require frequent blood transfusions or have increased dietary iron absorption.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to remove excess iron from the body (chronic iron overload) in patients with beta thalassemia major who receive frequent transfusions, as well as in other types of anemias or thalassemia syndromes under certain conditions.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to remove excess iron from the body (chronic iron overload). It is indicated for patients with beta thalassemia major who receive frequent transfusions, as well as for other types of anemia or thalassemia syndromes in specific cases where other treatments are not suitable.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassemia major (from 6 years of age onwards). It is also used in other types of anemia or thalassemia syndromes when other treatments are not suitable.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassemia major (6 years of age or older). It is also used in other types of anemias and in children aged 2 to 5 years when other treatments are unsuitable or contraindicated.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassemia major (from age 6 and older). It is also used in other types of anemias and in children aged 2 to 5 years when other treatments are not suitable, as well as in patients aged 10 years or older with thalassemia syndromes who are not transfusion-dependent.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassemia major (from 6 years of age onwards). It is also used to treat iron overload in other types of anemias and in children aged 2 to 5 years, or in patients aged 10 years or older with non-transfusion-dependent thalassemia syndromes, provided that deferoxamine treatment is not suitable or is contraindicated.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassemia major (from 6 years of age onwards). It is also used in other types of anemias and in children aged 2 to 5 years when other treatments are not suitable or are contraindicated.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to remove excess iron from the body (chronic iron overload) in patients with beta thalassemia major who receive frequent transfusions, as well as in other types of anemia or thalassemia syndromes as per medical indications.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Vivanta Generics S.R.O.
-
It is used to remove excess iron from the body (chronic iron overload) in patients with beta thalassemia major, other types of anemias, or thalassemia syndromes, whether due to frequent blood transfusions or dietary iron absorption.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Zentiva K.S.
-
It is used to remove excess iron from the body (chronic iron overload). It is indicated for patients with beta thalassemia major who receive frequent transfusions, as well as for other types of anemias or thalassemia syndromes in children and adults, when other treatments are not suitable.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Zentiva K.S.
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta-thalassemia major (6 years of age or older). It is also used in other types of anemia and in children aged 2 to 5 years when other treatments are not suitable, as well as in individuals aged 10 years or older with non-transfusion-dependent thalassemia syndromes.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Novartis Europharm Limited
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta-thalassemia major (6 years of age and older). It is also used in other types of anemias and thalassemic syndromes in children and adults when other treatments are not suitable.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Novartis Europharm Limited
-
It is used to remove excess iron in the body (chronic iron overload). It is prescribed for patients with beta thalassemia major who receive frequent transfusions, for children aged 2 to 5 years with other types of anemia, and for individuals aged 10 years or older with thalassemia syndromes who are not transfusion-dependent.
Form: tablets, film-coated
Active substance Dosage deferasirox 360 mg Manufacturer: Bexal Farmaceutica S.A.
-
It is used to treat chronic iron overload caused by frequent blood transfusions in patients with beta thalassemia major (6 years of age or older). It is also used to treat iron overload in other types of anemias and in children aged 2 to 5 years when other treatments are not suitable.
Form: tablets, film-coated
Active substance Dosage deferasirox 90 mg Manufacturer: Bexal Farmaceutica S.A.